Targeted Strategies for Today's Evolving Markets

MissionIR Blog

EnteroMedics, Inc. (ETRM) Starts Presentation at 25th Annual ROTH Conference

EnteroMedics is a medical device company engaged in developing and commercializing its neuroscience-based technology for treating obesity and metabolic diseases. VBLOC vagal blocking therapy, the company’s proprietary technology, is delivered by a pacemaker-like device called the Maestro Rechargeable System and is designed to intermittently block the vagus nerves using high-frequency, low-energy electrical impulses. VBLOC enables people with obesity to take positive steps toward weight loss. For more information, visit the company’s Web site: http://www.enteromedics.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *